Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS

v3.24.2
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Jun. 30, 2024
Dec. 31, 2023
ASSETS    
Available-for-sale securities, at fair value (amortized cost $8,359,346 and $8,509,383, respectively; allowance for credit losses $3,340 and $3,943, respectively) $ 8,029,955 $ 8,327,149
Mortgage servicing rights, at fair value 3,065,415 3,052,016
Cash and cash equivalents 624,199 729,732
Restricted cash 162,623 65,101
Accrued interest receivable 35,993 35,339
Due from counterparties 372,192 323,224
Derivative assets, at fair value 13,519 85,291
Reverse repurchase agreements 349,660 284,091
Other assets 196,161 236,857
Total Assets 12,849,717 13,138,800
Liabilities    
Repurchase agreements 8,434,910 8,020,207
Revolving credit facilities 1,279,271 1,329,171
Term notes payable 0 295,271
Convertible senior notes 259,412 268,582
Derivative liabilities, at fair value 14,264 21,506
Due to counterparties 352,117 574,735
Dividends payable 58,729 58,731
Accrued interest payable 85,680 141,773
Commitments and contingencies (see Note 16) 0 0
Other liabilities 170,037 225,434
Total Liabilities 10,654,420 10,935,410
Stockholders' Equity    
Preferred stock, par value $0.01 per share; 100,000,000 shares authorized and 24,870,817 and 25,356,426 shares issued and outstanding, respectively ($621,770 and $633,911 liquidation preference, respectively) 601,467 613,213
Common stock, par value $0.01 per share; 175,000,000 shares authorized and 103,622,239 and 103,206,457 shares issued and outstanding, respectively 1,036 1,032
Additional paid-in capital 5,933,250 5,925,424
Accumulated other comprehensive loss (323,580) (176,429)
Cumulative earnings 1,610,541 1,349,973
Cumulative distributions to stockholders (5,627,417) (5,509,823)
Total Stockholders’ Equity 2,195,297 2,203,390
Total Liabilities and Stockholders’ Equity $ 12,849,717 $ 13,138,800